- Home
- SLN vs BWB Comparison
SLN vs BWB Comparison
Compare SLN & BWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- BWB
- Stock Information
- Founded
- SLN 1994
- BWB 2005
- Country
- SLN United Kingdom
- BWB United States
- Employees
- SLN N/A
- BWB N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- BWB Major Banks
- Sector
- SLN Health Care
- BWB Finance
- Exchange
- SLN Nasdaq
- BWB Nasdaq
- Market Cap
- SLN 352.2M
- BWB 365.0M
- IPO Year
- SLN N/A
- BWB 2018
- Fundamental
- Price
- SLN $5.12
- BWB $13.28
- Analyst Decision
- SLN Strong Buy
- BWB Strong Buy
- Analyst Count
- SLN 4
- BWB 2
- Target Price
- SLN $61.50
- BWB $17.00
- AVG Volume (30 Days)
- SLN 460.0K
- BWB 62.1K
- Earning Date
- SLN 03-11-2025
- BWB 01-29-2025
- Dividend Yield
- SLN N/A
- BWB N/A
- EPS Growth
- SLN N/A
- BWB N/A
- EPS
- SLN N/A
- BWB 1.05
- Revenue
- SLN $21,773,221.00
- BWB $105,684,000.00
- Revenue This Year
- SLN N/A
- BWB N/A
- Revenue Next Year
- SLN $104.98
- BWB $18.90
- P/E Ratio
- SLN N/A
- BWB $12.65
- Revenue Growth
- SLN N/A
- BWB N/A
- 52 Week Low
- SLN $4.82
- BWB $10.52
- 52 Week High
- SLN $27.72
- BWB $16.00
- Technical
- Relative Strength Index (RSI)
- SLN 25.52
- BWB 41.93
- Support Level
- SLN $4.82
- BWB $13.03
- Resistance Level
- SLN $7.87
- BWB $13.37
- Average True Range (ATR)
- SLN 0.62
- BWB 0.31
- MACD
- SLN -0.01
- BWB 0.04
- Stochastic Oscillator
- SLN 9.20
- BWB 64.39
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid. its pipeline products are; SLN360 therapy designed to temporarily block a specific gene's message that would otherwise trigger an unwanted effect. By silencing the LPA gene, the levels of Lp(a) are lowered, which in turn is expected to lower the risks of heart diseases, heart attacks, and strokes, and SLN124 therapy aims to temporarily silence TMPRSS6, a gene that prevents the liver from producing a particular hormone that controls iron levels in the body hepcidin. As hepcidin increases, iron levels in the blood are expected to decrease, which may increase the production of healthy red blood cells, thereby reducing anemia.
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc offers retail and commercial loan and deposit services to customers within the Minneapolis-St. Paul-Bloomington, MN-WI Metropolitan Statistical Area. The company engages in providing a wide range of deposit and lending products. Its products and services include commercial deposits, loans, online business services, credit card, mobile banking, and remote deposit services.